Small molecule therapeutics for schizophrenia / edited by Sylvain Celanire, Sonia Poli.
Tipo de material:
TextoSeries Topics in Medicinal Chemistry ; 13Editor: Cham : Springer International Publishing : Springer, 2015Descripción: vii, 323 páginas : 185 ilustraciones, 23 ilustraciones en colorTipo de contenido: - texto
- computadora
- recurso en línea
- 9783319115023
- RS400-431
Contenidos:
Antipsychotics and the Dopamine–Serotonin Connection -- GLYT1 Inhibitors: From Hits to Clinical Candidates -- Metabotropic Glutamate Receptor 2 Activators -- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders -- Muscarinic Acetylcholine Receptor Activators -- Nicotinic Acetylcholine Receptor Modulators -- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
No hay ítems correspondientes a este registro
Springer eBooks
Antipsychotics and the Dopamine–Serotonin Connection -- GLYT1 Inhibitors: From Hits to Clinical Candidates -- Metabotropic Glutamate Receptor 2 Activators -- Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders -- Muscarinic Acetylcholine Receptor Activators -- Nicotinic Acetylcholine Receptor Modulators -- The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia.
Para consulta fuera de la UANL se requiere clave de acceso remoto.